TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9761130

Group type: EXPERIMENTAL
Intervention: I2 (iodine) at doses of 0.3 or 1 mg/kg body weight
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: I- (iodide) at doses of 0.3 or 1 mg/kg body weight
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 33
Study: 7531032

Group type: EXPERIMENTAL
Intervention: Electrostatic therapy (EST) with low voltage (200 to 1200 V)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Electrostatic therapy (EST) with high voltage (500 to 2500 V)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Electrostatic therapy (EST) with high voltage together with high magnetic field
Number of subjects: 15
Study: 3139379

Group type: EXPERIMENTAL
Intervention: Misoprostol 400 micrograms twice daily
Number of subjects: 416

Group type: COMPARATOR
Intervention: Misoprostol 200 micrograms four times daily
Number of subjects: 416
Study: 31606903

Group type: EXPERIMENTAL
Intervention: Pectin-containing oligomeric formula (POF)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard polymeric formula (SPF)
Number of subjects: 201
Study: 31129386

Group type: COMPARATOR
Intervention: mFOLFOX6 alone
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: mFOLFOX6 + panitumumab (6 mg/kg)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: mFOLFOX6 + rilotumumab (10 mg/kg)
Number of subjects: 162
Study: 29087166

Group type: EXPERIMENTAL
Intervention: Adherence packaging intervention group
Number of subjects: 240

Group type: COMPARATOR
Intervention: Education-only control group
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 240
Study: 27444426

Group type: EXPERIMENTAL
Intervention: Interviewer-administration of the TAPS Tool
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self-administration of the TAPS Tool
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: TAPS Tool
Number of subjects: 2000
Study: 24557022

Group type: EXPERIMENTAL
Intervention: 30 mg/kg bolus and continuous infusion of 16 mg/kg/h (Group HIGH)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 5 mg/kg bolus followed by 5 mg/kg/h (Group LOW)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sodium chloride (Placebo)
Number of subjects: 33
Study: 22385927

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 19456308

Group type: EXPERIMENTAL
Intervention: Intranasal diazepam (DZP) 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal midazolam (MDZ) 5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous diazepam (DZP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous midazolam (MDZ)
Number of subjects: 0
Study: 17890994

Group type: EXPERIMENTAL
Intervention: Group academic detailing with physician-level performance feedback
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study: 15272537

Group type: EXPERIMENTAL
Intervention: hASH1 mRNA levels in esthesioneuroblastomas
Number of subjects: 24

Group type: COMPARATOR
Intervention: hASH1 mRNA levels
Number of subjects: 24
Study: 11354393

Group type: COMPARATOR
Intervention: Placebo (10% response rate)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Investigational drug (70% response rate)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Investigational drug (70% response) vs Standard therapy (60% response)
Number of subjects: 24
Study: 10465074

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lymph node needle aspiration
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard excisional biopsy
Number of subjects: 6
Study: 7598872

Group type: EXPERIMENTAL
Intervention: Composite myo-mucosal reconstruction of the vocal fold using a muscular flap and free mucosal transplant
Number of subjects: 11
Study: 2190897

Group type: EXPERIMENTAL
Intervention: Roxithromycin 150 mg b.i.d. p.o. for ten days
Number of subjects: 210

Group type: COMPARATOR
Intervention: Doxycycline 100 mg b.i.d. p.o. for ten days
Number of subjects: 210
Study: 24401

Group type: EXPERIMENTAL
Intervention: LS-bicarbonate dialysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: LS-carbonate dialysis
Number of subjects: 0
Study: 30918030

Group type: EXPERIMENTAL
Intervention: High-intensity intervention programme (weekly group sessions for 12 months)
Number of subjects: 96
Study: 28124514

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham-RIPC
Number of subjects: 32
Study: 24733234

Group type: EXPERIMENTAL
Intervention: Cognitive function measured by the Trail Making Test in people with COPD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive function
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age, gender, education, and income
Number of subjects: 0
Study: 24434160

Group type: EXPERIMENTAL
Intervention: Luoghi di Prevenzione‐Prevention Grounds programme (intervention)
Number of subjects: 989
Study: 22496767

Group type: EXPERIMENTAL
Intervention: Caffeine ingestion (3 mg kg(‐1); AM(CAFF) trial)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo ingestion (AM(PLAC) trial)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo ingestion (PM(PLAC) trial)
Number of subjects: 12
Study: 19942023

Group type: EXPERIMENTAL
Intervention: Intervention group received two individual registered dietitian‐led in‐home education sessions.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group received education material mailings (Visits 2 and 3).
Number of subjects: 58
Study: 17445347

Group type: EXPERIMENTAL
Intervention: Flavonoid-rich diet for 1 month
Number of subjects: 30
Study: 15340356

Group type: EXPERIMENTAL
Intervention: A allele carriers of the ECE1B C-338A variant
Number of subjects: 401

Group type: COMPARATOR
Intervention: Control group (aged controls)
Number of subjects: 401
Study: 11588025

Group type: EXPERIMENTAL
Intervention: ChOP
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: CAP
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: fludarabine (FAMP)
Number of subjects: 938
Study: 9699585

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg intravenously before bypass and 33 mg/hr infusion after operation until the fifth postoperative day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional perioperative therapy
Number of subjects: 20
Study: 8137335

Group type: EXPERIMENTAL
Intervention: Beta-carotene (30 mg/day) plus retinyl palmitate (25,000 IU/day)
Number of subjects: 15105

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 15105
Study: 2802363

Group type: EXPERIMENTAL
Intervention: Preventive treatment with one of three different fixed drug combinations containing isoniazid
Number of subjects: 808

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 808
Study: 108043

Group type: EXPERIMENTAL
Intervention: Ethane-1-hydroxy-1,1-diphosphonate (EHDP) 4.4 mmol daily for 12 months
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo after 12 months of EHDP treatment
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: EHDP treatment
Number of subjects: 9
Study: 30047159

Group type: EXPERIMENTAL
Intervention: Randomization
Number of subjects: 0
Study: 28538983

Group type: EXPERIMENTAL
Intervention: Medium-fidelity simulation (synthetic anatomy for surgical tasks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation (deceased donor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (SimMan, no surgical anatomy)
Number of subjects: 0
Study: 25486415

Group type: EXPERIMENTAL
Intervention: TB-IRIS patients
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Post-ART initiation in TB-IRIS patients
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: TB-IRIS patients at week 34 post-TB treatment initiation
Number of subjects: 154

Group type: COMPARATOR
Intervention: Non-TB-IRIS patients
Number of subjects: 154
Study: 23041000

Group type: COMPARATOR
Intervention: Euthyroid patients
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: Subclinical hyperthyroidism
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: Hypothyroidism
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: Subclinical thyroid dysfunction
Number of subjects: 758
Study: 16452331

Group type: EXPERIMENTAL
Intervention: Maternal multivitamin supplementation
Number of subjects: 327

Group type: COMPARATOR
Intervention: Vitamin A supplementation
Number of subjects: 327
Study: 15291857

Group type: EXPERIMENTAL
Intervention: Increased biopsy cores (8, 10, 12, 14 cores based on prostate volume)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Sextant biopsy (standard 6 cores)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Increased biopsy cores
Number of subjects: 132
Study: 10828670

Group type: EXPERIMENTAL
Intervention: TURP
Number of subjects: 95

Group type: COMPARATOR
Intervention: TUVP
Number of subjects: 95

Group type: COMPARATOR
Intervention: VLAP
Number of subjects: 95

Group type: COMPARATOR
Intervention: HIFU
Number of subjects: 95

Group type: COMPARATOR
Intervention: TUNA
Number of subjects: 95
Study: 8650418

Group type: EXPERIMENTAL
Intervention: Ultrasonic nebuliser (DP100)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Pneumatic nebuliser (Pari LL)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Both nebulisers
Number of subjects: 4
Study: 1628135

Group type: EXPERIMENTAL
Intervention: recombinant human GM‐CSF (rhGM‐CSF) after allogeneic bone marrow transplantation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (20 patients)
Number of subjects: 20
Study: 6385229

Group type: EXPERIMENTAL
Intervention: Cyclosporin A
Number of subjects: 11

Group type: COMPARATOR
Intervention: Azathioprine/steroids
Number of subjects: 11
Study: 30762467

Group type: EXPERIMENTAL
Intervention: Intramuscular split-virion quadrivalent inactivated influenza vaccine (IIV4; Fluzone® Quadrivalent)
Number of subjects: 100
Study: 27898234

Group type: EXPERIMENTAL
Intervention: Lumacaftor/Ivacaftor (400 mg/250 mg every 12 h)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 25417892

Group type: EXPERIMENTAL
Intervention: de novo CRT-D (CRT with ICD) implant
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: study upgrade to CRT-D
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: substudy CRT attempts
Number of subjects: 1346
Study: 23534952

Group type: EXPERIMENTAL
Intervention: 5 μg∙kg(‐1) phenylephrine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Intravenous placebo
Number of subjects: 22
Study: 21570352

Group type: EXPERIMENTAL
Intervention: Taxane-based regimen (T-ET): three cycles of docetaxel 100 mg/m² followed by three cycles of intravenous epirubicin 90 mg/m² and docetaxel 75 mg/m².
Number of subjects: 1856

Group type: COMPARATOR
Intervention: Anthracycline regimen (FEC): six cycles of intravenous fluorouracil 500 mg/m², epirubicin 100 mg/m², and cyclophosphamide 500 mg/m² or fluorouracil 600 mg/m², epirubicin 75 mg/m², cyclophosphamide 900 mg/m².
Number of subjects: 1856

Group type: EXPERIMENTAL
Intervention: Overall for all patients, irrespective of TP53 status.
Number of subjects: 1856

Group type: COMPARATOR
Intervention: Taxane-based regimen (T-ET) and Anthracycline regimen (FEC) adverse events.
Number of subjects: 1856
Study: 19225525

Group type: EXPERIMENTAL
Intervention: Recombinant human superoxide dismutase (rhSOD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 17142706

Group type: EXPERIMENTAL
Intervention: MR venography with true fast imaging with steady-state precession (FISP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Contrast agent-enhanced venography
Number of subjects: 24
Study: 12750069

Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 10620550

Group type: EXPERIMENTAL
Intervention: Vitamin E-coated (VE) dialyzer
Number of subjects: 21

Group type: COMPARATOR
Intervention: Synthetic polyamide (PA) dialyzer
Number of subjects: 21
Study: 8811519

Group type: EXPERIMENTAL
Intervention: Calorie-dense milk (5.0 kJ/ml with a protein-energy ratio of 11.0)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control milk formula (2.5 kJ/ml with a protein-energy ratio of 11.0)
Number of subjects: 23
Study: 1393487

Group type: EXPERIMENTAL
Intervention: Haemoccult screening test
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Haemoccult screening test for sigmoid and descending colon cancers
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Haemoccult screening test for rectal cancers
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Haemoccult screening test for right-sided cancers
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Haemoccult screening test completed over 6 days
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Haemoccult screening test completed over 3 days
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Interval cancers in the Haemoccult group
Number of subjects: 111
Study: 3866069

Group type: EXPERIMENTAL
Intervention: Simple occlusal adjustment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Mock adjustment (placebo)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: All patients (including those from both groups)
Number of subjects: 22
Study: 31103781

Group type: EXPERIMENTAL
Intervention: Hokkien caregiving
Number of subjects: 0

Group type: COMPARATOR
Intervention: English-only caregiving (Control)
Number of subjects: 0
Study: 30466489

Group type: EXPERIMENTAL
Intervention: Medical students
Number of subjects: 3897
Study: 27249005

Group type: EXPERIMENTAL
Intervention: 300 U BoNT‐A injection into the detrusor every six months
Number of subjects: 20
Study: 25061252

Group type: EXPERIMENTAL
Intervention: Oral Pressure Therapy (OPT) device
Number of subjects: 19
Study: 22777041

Group type: EXPERIMENTAL
Intervention: ST-246 400 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ST-246 600 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ST-246 400 mg and 600 mg
Number of subjects: 0
Study: 19416278

Group type: EXPERIMENTAL
Intervention: Locator self-aligning attachment system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TG-O-Ring attachment system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dal-Ro abutment
Number of subjects: 60

Group type: COMPARATOR
Intervention: All systems
Number of subjects: 60
Study: 18042519

Group type: EXPERIMENTAL
Intervention: PSPLs diet (200 g PSPLs/d; weeks 2, 3)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control diet (weeks 6 and 7)
Number of subjects: 15
Study: 16118310

Group type: EXPERIMENTAL
Intervention: Protective Eyewear Promotion (PEP) project
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (usual practice)
Number of subjects: 0
Study: 11821457

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg orally once daily for 6 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg orally once daily for 6 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison of Anastrozole and Letrozole
Number of subjects: 12
Study: 10348967

Group type: EXPERIMENTAL
Intervention: Exogenous antioxidants, primarily vitamin E
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Large doses of antioxidants
Number of subjects: 0
Study: 7548700

Group type: EXPERIMENTAL
Intervention: Mantel‐Haenszel mean score statistic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mean score test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weighted average of the center‐specific mean differences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed‐effects analysis of variance estimator
Number of subjects: 0
Study: 1911657

Group type: EXPERIMENTAL
Intervention: Acyclovir (ACV) ointment and placebo drops (AP)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo ointment with steroid drops (PS)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Acyclovir ointment with steroid drops (AS)
Number of subjects: 97
Study: 6783231

Group type: EXPERIMENTAL
Intervention: Sustained-release theophylline
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30039978

Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban regimen
Number of subjects: 21105

Group type: COMPARATOR
Intervention: Lower-dose edoxaban regimen
Number of subjects: 21105
Study: 27757774

Group type: EXPERIMENTAL
Intervention: Modified 7-factor model
Number of subjects: 663

Group type: COMPARATOR
Intervention: 5-factor model
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Internal consistency
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: Ceiling effects
Number of subjects: 663
Study: 26358968

Group type: EXPERIMENTAL
Intervention: iRDT (BD Directigen A + B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 100
Study: 23549690

Group type: EXPERIMENTAL
Intervention: Water aerobic exercises at different intensities in aquatic environment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water aerobic exercises at different intensities in dry land environment
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cross country skiing in aquatic environment
Number of subjects: 15
Study: 20303230

Group type: EXPERIMENTAL
Intervention: Communication skills course (7-hour course using AFLS methodology)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 33
Study: 19774423

Group type: EXPERIMENTAL
Intervention: Mailed educational reminder
Number of subjects: 775

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 775
Study: 17597952

Group type: EXPERIMENTAL
Intervention: Peer tutor review sessions
Number of subjects: 51

Group type: COMPARATOR
Intervention: Approved Clinical Instructor review sessions
Number of subjects: 51
Study: 15149421

Group type: EXPERIMENTAL
Intervention: Segmental ostial PV isolation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Circumferential extra-ostial PV isolation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study: 11546902

Group type: EXPERIMENTAL
Intervention: 10 mg dextroamphetamine
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 9039254

Group type: EXPERIMENTAL
Intervention: Automatic NCPAP titration (Horizon, DeVilbiss)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Manual NCPAP titration
Number of subjects: 122
Study: 7960016

Group type: EXPERIMENTAL
Intervention: High cardiorespiratory fitness (VO2peak 46.6 +/- 6.5 mL.kg-1.min-1)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Moderate cardiorespiratory fitness (VO2peak 35.9 +/- 1.9 mL.kg-1.min-1)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: High physical activity (1217.7 +/- 98.4 J.kg-1.wk-1)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Moderate physical activity (1015.5 +/- 49.4 J.kg-1.wk-1)
Number of subjects: 31
Study: 3236323

Group type: EXPERIMENTAL
Intervention: Twice daily nitrendipine (20 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Once daily nitrendipine (20 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 31749028

Group type: EXPERIMENTAL
Intervention: CommunityRx intervention
Number of subjects: 374
Study: 30475968

Group type: EXPERIMENTAL
Intervention: Mediterranean diet rich in olive oil (MedDiet)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Low-fat diet (LF)
Number of subjects: 241
Study: 28658562

Group type: EXPERIMENTAL
Intervention: Mother-Infant Psychoanalysis (MIP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard child health center care
Number of subjects: 10
Study: 25742730

Group type: EXPERIMENTAL
Intervention: Saquinavir/ritonavir 500/100 mg BID on days 1-7 and 1000/100 mg BID on days 8-14
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Saquinavir/ritonavir regimen
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Modified saquinavir/ritonavir regimen
Number of subjects: 23
Study: 23937034

Group type: EXPERIMENTAL
Intervention: Minimally invasive PHILOS fixation combined with injectable bone
Number of subjects: 80

Group type: COMPARATOR
Intervention: PHILOS fixation
Number of subjects: 80
Study: 20463104

Group type: EXPERIMENTAL
Intervention: HIV-1 DNA vaccine (intradermally or intramuscularly) with GM-CSF adjuvant, boosted with modified vaccinia virus Ankara (HIV-MVA) at 9 months
Number of subjects: 38
Study: 18208743

Group type: EXPERIMENTAL
Intervention: Closed with polyglycolic mesh (Group B)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Simple closed laparotomy (Group A)
Number of subjects: 143
Study: 16882101

Group type: EXPERIMENTAL
Intervention: Sun ginseng (SG) 3000 mg a day
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 14696886

Group type: EXPERIMENTAL
Intervention: Retrobulbar anesthesia with preservative-free bupivacaine hydrochloride 0.5%
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intracameral anesthesia with preservative-free bupivacaine hydrochloride 0.5%
Number of subjects: 200
Study: 10534036

Group type: EXPERIMENTAL
Intervention: 125 mg of intravenous methyl prednisolone administered prehospital to asthma patients (11 patients in year 2)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group (patients who did not receive prehospital steroids)
Number of subjects: 219
Study: 8704017

Group type: EXPERIMENTAL
Intervention: Medium chain triglycerides and long chain triglycerides (MCT/LCT) in a ratio of 1:1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long chain triglycerides (LCT)
Number of subjects: 0
Study: 1888422

Group type: EXPERIMENTAL
Intervention: halothane‐N2O/O2‐anaesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: isoflurane‐N2O/O2‐anaesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: midazolam‐fentanyl‐N2O/O2‐anaesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: midazolam‐ketamine‐N2O/O2‐anaesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: tramadol‐N2O/O2‐anaesthesia
Number of subjects: 40
Study: 6353878

Group type: EXPERIMENTAL
Intervention: 0.075 mg clonidine at 8 a.m. and 0.15 mg at 10 p.m.
Number of subjects: 10
Study: 4064110

Group type: EXPERIMENTAL
Intervention: Arterial sheath
Number of subjects: 184

Group type: COMPARATOR
Intervention: Standard Seldinger technique (Control)
Number of subjects: 184
Study: 29846794

Group type: EXPERIMENTAL
Intervention: Combined resistance and aerobic exercise training (CRAE) for 12 weeks, 5 times per week, intensity increased from 40 to 70% HRR
Number of subjects: 40

Group type: COMPARATOR
Intervention: No exercise (CON)
Number of subjects: 40
Study: 27876029

Group type: EXPERIMENTAL
Intervention: Telemonitoring (TM) system
Number of subjects: 334

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 334